stockrowInvivyd, Inc. (IVVD) vs Entrada Therapeutics, Inc. (TRDA)
- Invivyd, Inc. IVVD 0.56 −5.08%
- Entrada Therapeutics, Inc. TRDA 4.89 +7.47%
Invivyd, Inc. and Entrada Therapeutics, Inc. are both Biotechnology companies. Entrada Therapeutics, Inc. is the larger, with a market value of $191.5M against $166.0M — 1.2× the size. Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −93.5%. Invivyd, Inc. has the higher net margin (−183.9% vs −4,058.0%) and the higher return on invested capital (−334.9% vs −2,009.0%). Across the 16 metrics below, Invivyd, Inc. leads on 11 and Entrada Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | IVVD | TRDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 100.00% | 68.51% |
| Operating margin | (192.81%) | (4,303.82%) | 0.00% |
| Net margin | (183.90%) | (4,057.98%) | 0.00% |
| Free cash flow margin | (187.88%) | (3,428.06%) | 0.00% |
| Return on equity | (95.89%) | (59.88%) | (51.96%) |
| Return on assets | (69.69%) | (47.48%) | (46.06%) |
| Return on invested capital | (334.92%) | (2,008.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack